|
Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting.
Stroke. 2003 Nov; 34(11):2560-7. Epub 2003 Nov 16
Kopp CW, Steiner S, Nasel C, Seidinger D, Mlekusch I, Lang W, Bartok A, Ahmadi R, Minar E |
|
Coagulation activation and long-term outcome in acute coronary syndromes.
Blood. 2003 Oct; 108(8):2731-5. Epub 2003 Jul 3
Ardissino D, Merlini PA, Bauer KA, Galvani M, Ottani F, Franchi F, Bertocchi F, Rosenberg RD, Mannucci PM. |
|
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Circulation. 2003 Oct; 108(15):1822-30. Epub 2003 Sep 29
Festa A, Hanley AJ, Tracy RP, D´Agostino R Jr, Haffner SM. |
|
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
N Engl J Med. 2003 Oct; 348(15):1425-34. Epub 2003 Feb 24
Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators |
|
Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
Circulation. 2003 Sep; 108(13):1581-4. Epub 2003 Sep 15
Tutar E, Ozcan M, Kilickap M, Gulec S, Aras O, Pamir G, Oral D, Dandelet L, Key NS. |
|
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Circulation. 2003 Sep; 108(11):1316-23. Epub 2003 Ago 25
Tcheng JE, Kandzari DE, Grines CL, Cox DA, Effron MB, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Mehran R, Stone GW; CADILLAC Investigators |
|
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.
Blood. 2003 Sep; 102(6):2038-45. Epub 2003 May 22
Powell JS, Ragni MV, White GC 2nd, Lusher JM, Hillman-Wiseman C, Moon TE, Cole V, Ramanathan-Girish S, Roehl H, Sajjadi N, Jolly DJ, Hurst D. |
|
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
Circulation. 2003 Sep; 108(23):2851-6. Epub 2003 Nov 17
Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P; Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. |
|
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
Circulation. 2003 Sep; 108(10):1176-83. Epub 2003 Ago 18
Mahaffey KW, Granger CB, Nicolau JC, Ruzyllo W, Weaver WD, Theroux P, Hochman JS, Filloon TG, Mojcik CF, Todaro TG, Armstrong PW; COMPLY Investigators. |
|
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs.
Circulation. 2003 Sep; 108(10):1191-5. Epub 2003 Ago 25
Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, Gaziano JM. |
|
Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Str
Circulation. 2003 Sep; 108(10):1278-90.
Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, Taubert KA; Stroke Council and the Council on Clinical Cardiology of the American Heart Association; American Stroke Association |
|
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.
Circulation. 2003 Sep; 108(9):1059-63. Epub 2003 Ago 11
Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, Stuehlinger M, Lin KY, Cooke JP, Morrow JD, Ridker PM, Rifai N, Miller E, Witztum JL, Mietus-Snyder M |
|
Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters).
Circulation. 2003 Sep; 108(9):1064-9.
Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M, van der Zee R, Gaston H, Jarosch E, Willeit J, Wick G. |
|
Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Circulation. 2003 Sep; 108(9):1119-27. Epub 2003 Ago 25
Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A, Grgic I, Kampfe D, Si H, Wibawa J, Real R, Borner K, Brakemeier S, Orzechowski HD, Reusch HP, Paul M, Chandy KG, Hoyer J. |
|
Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.
Circulation. 2003 Sep; 108(9):1078-83. Epub 2003 Ago 18
Mehran R, Aymong ED, Ashby DT, Fischell T, Whitworth H Jr, Siegel R, Thomas W, Wong SC, Narasimaiah R, Lansky AJ, Leon MB. |
|
Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
Circulation. 2003 Ago; 108(8):921-4. Epub 2003 Ago 18
Saw J, Steinhubl SR, Berger PB, Kereiakes DJ, Serebruany VL, Brennan D, Topol EJ; Clopidogrel for the Reduction of Events During Observation Investigators. |
|
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
N Engl J Med. 2003 Ago; 349(8):733-42.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12930925&dopt=Abstract |
|
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.
J Am Coll Cardiol.. 2003 Ago; 42(4):661-7.
Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG; Copenhagen City Heart Study. |
|
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
Lancet. 2003 Ago; 362(9383):523-6.
Baglin T, Luddington R, Brown K, Baglin C |
|
Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis.
Circulation. 2003 Ago; 107(13):1757-63. Epub 2003 Mar 24
Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. |
